Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Not yet recruiting × ESCC × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 19 Breast Neoplasms 18 Neoplasms 17 Colorectal Neoplasms 17 Multiple Myeloma 14 Advanced Solid Tumors 12 Prostatic Neoplasms 10 Pancreatic Neoplasms 10 Recurrence 9 Ovarian Neoplasms 9 Leukemia, Myeloid, Acute 9 Triple Negative Breast Neoplasms 8 Stomach Neoplasms 8 Small Cell Lung Carcinoma 8 Carcinoma, Hepatocellular 8 Advanced Solid Tumor 8 Melanoma 7 Glioblastoma 7 Squamous Cell Carcinoma of Head and Neck 6 Lymphoma, B-Cell 6 Head and Neck Neoplasms 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 5 Lung Neoplasms 5 Solid Tumor 4 Non-Muscle Invasive Bladder Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia 4 Glioma 4

Interventions

trifluridine tipiracil drug combination 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07196345 2025-09-29

TAS-102 Plus Radiotherapy in Elderly ESCC

Qianfoshan Hospital

Phase 1/2 Not yet recruiting

ESCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡